The Valley Desk

NCT06844214 · Interventional trial

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Myotonic Dystrophy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov